期刊文献+

Toll样受体4在非肥胖型糖尿病鼠胰腺组织的特异性分布表达及其意义

Specific expression and significance of Toil-like receptor 4 in pancreatic tissue of non-obesediabetic mice
原文传递
导出
摘要 目的检测Toll样受体4(TLR4)在非肥胖型糖尿病(NOD)鼠胰腺的表达及发病过程中的变化,并探讨其临床意义。方法利用免疫荧光定位TLR4在胰腺中的表达,采用逆转录一聚合酶链反应(RT—PCR)及Western blot等方法分别从mRNA和蛋白水平探讨其在胰腺中的表达及发病过程中的变化。结果几乎所有的胰岛p细胞表面均表达TLR4。随着1型糖尿病的进展,胰腺TLR4蛋白相对表达量由1.01±0.01上升到3.68±0.10,组间差异有统计学意义(P〈0.01);mRNA相对表达量由1.00±0.02上升到4.76±0.17,组间差异有统计学意义(P〈0.01)。结论随着1型糖尿病的进展,TLR4表达明显增加,其可能通过免疫机制参与了疾病的发生、发展过程。 Objective To detect the expression of Toll-hke receptor 4 (TLR4) in pancreas of non-obesediabetic (NOD) mice and the change in the pathogenesis in order to explore their clinical significance. Methods Immunofluoreseence was used to detect the location of TLR4 in pancreas, reverse tran-scription-polymerase chain reaction (RT-PCR) and Western blotting were employed to examine its mRNA and protein expression changes in the pathogenesis of type 1 diabetes separately. Results TLR4 was expressed on almost all the surface of 13 islet cells. With the development of the type 1 diabetes, the relative expression of TLR4 was elevated from ( 1.01±0.01 ) to (3.68 ±0. 10), P 〈0. 01; the relative expression of TLR4 mRNA was elevated from ( 1.00±0. 02) to (4. 76±0. 17), P 〈0. 01. Conclusion The expression of TLR4 is significantly increased with the progress of type 1 diabetes, suggesting that TLR4 may participate in the occurrence and development of type 1 diabetes by immune mechanisms.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第1期33-35,共3页 Chinese Journal of Experimental Surgery
基金 国家教育部博士点基金资助项目(20090071110019) 上海市自然科学基金资助项目(09ZR1405900) 复旦大学重点学科优秀博士生科研资助计划 复旦大学一生物医学研究院科研合作基金资助项目
关键词 1型糖尿病 TOLL样受体4 胰腺 Type 1 diabetes Toll-like receptor 4 Pancreas
  • 相关文献

参考文献11

  • 1Medzhitov R, Prestonhurlburt P, Janeway CA. A human homologue of the drosophila Toll protein signals activation of adaptive immunity. Nature, 1997,388:394-397.
  • 2李园,周总光,张杰,郑雪莲,胡廷泽.Toll样受体4在大鼠胰腺组织的特异性分布表达[J].中国普外基础与临床杂志,2004,11(5):420-423. 被引量:2
  • 3周晓妮,杨欢,温会燕,周惠琴,冯萍,朱雪明.Toll样受体在不同转移能力人乳腺癌细胞株中的差异表达及意义[J].中华实验外科杂志,2011,28(5):662-664. 被引量:3
  • 4Oh GS, Kim HI, Choi JH, et al. Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of eisplatin in mice. J Im- munol,2011,186 : 1140-1150.
  • 5Goncalves GM, Castoldi A, Braga TT, et al. New roles for innate im- mune response in acute and chronic kidney injuries. Scand J Immu- nol,2011,73 :428-435.
  • 6Garay-Malpartida HM, Mourao RF, Mantovani M, et al. Toll-like re- ceptor 4 (TLR4) expression in human and murine pancreatic beta- ceils affects cell viability and insulin homeostasis. BMC Immunol, 2011,12:18.
  • 7Pino SC, Kruger AJ, Bortell R. The role of innate immune pathways in type 1 diabetes pathogenesis. Curr Opi Endocrinol Diabetes Obes, 2010,17 : 126-130.
  • 8李煜环,宋振顺,范子扬,张福琴.骨髓间充质干细胞体外对1型糖尿病大鼠淋巴细胞的免疫调节作用[J].中华实验外科杂志,2011,28(2):209-211. 被引量:12
  • 9Devaraj S, Dasu MR, Rockwood J, et al. Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes : Further evidence of a proinflammatory state. J Clini Endo & Metabo ,2008,93:578-583.
  • 10Meyers A J, Shah RR, Gottlieb PA, et al. Altered toll-like receptor sig- naling pathways in human type 1 diabetes. J Mol Med (Berl) ,2010, 88:1221-1231.

二级参考文献26

  • 1栾希英,张光波,胡玉敏,於葛华,王明元,段巧艳,段祥,张学光.人骨髓MSC对PHA活化T细胞周期以及表型和细胞因子分泌的影响[J].细胞与分子免疫学杂志,2007,23(5):402-405. 被引量:16
  • 2Abdi R,Fiorina P,Adra CN,et al.Immunomodulation by mesenchymal stem cells:a potential therapeutic strategy for type 1 diabetes.Diabetes,2008,57:1759-1767.
  • 3Selmani Z,Naji A,Zidi I,et al.Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25 + high-FOXP3 + regulatory T cells.Stem Cells,2008,26:212-222.
  • 4Sensebe L,Bourin P.Mesenchymal sten cells for therapeutic purposes.Transplantation,2009,87:49-53.
  • 5Tritt M,Sgouroudis E,D' Hennezel E,et al.Functional waning of naturally occurring CD4 + regulatory T-cells contributes to the onset of autoimmune diabetes.Diabetes,2008,57:113-123.
  • 6Glennie S,Soeiro I,Dyson PJ,et al.Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.Blood,2005,105:2821-2827.
  • 7Hashimoto C,Hudson KL,Anderson KV.The Toll gene of drosophila,required for dorsal-ventral embryonic polarity,appears to encode a transmembrane protein.Cell,1988,52:269-279.
  • 8Medzhitov R,Preston-Hurlburt P,Janeway CA.A human homologue of the drosophila Toll protein signals activation of adaptive immunity.Nature,1997,388:394-397.
  • 9Bell JK,Mullen GE,Leifer CA,et al.Leucine-rich repeats and pathogen recognition in Toll-like receptors.Trends Immunol,2003,24:528-533.
  • 100' Neill LA.Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.Curr Top Microbiol Immunol,2002,270:47-61.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部